Health Professional Radio - Podcast

Capricor's CAP-1002 - COVID-19 Survival of Critical Patients

Informações:

Sinopsis

Dr. Linda Marbán, President, CEO and Director of Capricor Therapeutics discusses new data reporting 100 percent survival in critical COVID-19 patients that were treated with her team's off-the-shelf, cardiac cell therapy CAP-1002. These patients were part of six compassionate care cases treated at Cedars-Sinai Medical Center in Los Angeles, and following a review of the data, the FDA approved the company’s expanded access protocol to treat additional COVID-19 patients with this novel new therapeutic